Biglycan and decorin differentially regulate signaling in the fetal membranes

Matrix Biology

Volumn 35, Issue , 2014, Pages 266-275

  Wu, Zhiping ^a   Horgan, Casie E ^a   Carr, Olivia ^a   Owens, Rick T ^b   Iozzo, Renato V ^c   Lechner, Beatrice E ^a  

^a BROWN UNIVERSITY   (United States)

^b LIFECELL CORPORATION   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Fetal membranes; MMP; Smad; Small leucine rich proteoglycan; TGF ; TIMP

Indexed keywords

BIGLYCAN; COLLAGEN; COLLAGENASE 3; DECORIN; GELATINASE B; NEUTROPHIL COLLAGENASE; PROTEOGLYCAN; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TRANSFORMING GROWTH FACTOR BETA; BGN PROTEIN, MOUSE; DCN PROTEIN, MOUSE; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EHLERS DANLOS SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; FETUS; FETUS MEMBRANE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; MALE; MEMBRANE STABILIZATION; MESENCHYME CELL; MOUSE; NONHUMAN; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANALYSIS OF VARIANCE; ANIMAL; CULTURE TECHNIQUE; DISEASE MODEL; EMBRYO MEMBRANE; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; PREMATURITY; WESTERN BLOTTING;

MUS;

ANALYSIS OF VARIANCE; ANIMALS; BIGLYCAN; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; DECORIN; DISEASE MODELS, ANIMAL; DNA PRIMERS; EHLERS-DANLOS SYNDROME; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRAEMBRYONIC MEMBRANES; IMMUNOHISTOCHEMISTRY; MICE; PREMATURE BIRTH; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84901453190     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2013.12.006     Document Type: Article

References (77)

1. Ameye L., Young M.F. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 2002, 12:107R-116R.
2. Ameye L., Aria D., Jepsen K., Oldberg A., Xu T., Young M.F. Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J. 2002, 16:673-680.
3. Ananth C.V., Vintzileos A.M. Epidemiology of preterm birth and its clinical subtypes. J. Matern. Fetal Neonatal Med. 2006, 19:773-782.
4. Ang L.S., Boivin W.A., Williams S.J., Zhao H., Abraham T., Carmine-Simmen K., McManus B.M., Bleackley R.C., Granville D.J. Serpina3n attenuates granzyme B-mediated decorin cleavage and rupture in a murine model of aortic aneurysm. Cel Death Dis. 2011, 2:e209.
5. Babelova A., Moreth K., Tsalastra-Greul W., Zeng-Brouwers J., Eickelberg O., Young M.F., Bruckner P., Pfeilschifter J., Schaefer R.M., Grone H.J., Schaefer L. Biglycan, a danger signal that activates the NLRP3 inflammasome via Toll-like and P2X receptors. J. Biol. Chem. 2009, 284:24035-24048.
6. Baghy K., Horvath Z., Regos E., Kiss K., Schaff Z., Iozzo R.V., Kovalszky I. Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis. FEBS J. 2013, 280:2150-2164.
7. Barabas A.P. Ehlers-Danlos syndrome: associated with prematurity and premature rupture of foetal membranes; possible increase in incidence. Br. Med. J. 1966, 5515:682-684.
8. Barabas A.P. Vascular complications in the Ehlers-Danlos syndrome, with special reference to the "arterial type" or Sack's syndrome. J. Cardiovasc. Surg. (Torino) 1972, 13:160-167.
9. Berendsen A.D., Fisher L.W., Kilts T.M., Owens R.T., Robey P.G., Gutkind J.S., Young M.F. Modulation of canonical Wnt signaling by the extracellular matrix component biglycan. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:17022-17027.
10. Bi Y., Stuelten C.H., Kilts T., Wadhwa S., Iozzo R.V., Robey P.G., Chen X.D., Young M.F. Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. J. Biol. Chem. 2005, 280:30481-30489.
11. Brandan E., Gutierrez J. Role of skeletal muscle proteoglycans during myogenesis. Matrix Biol. 2013, 32:289-297.
12. Brown D.C., Vogel K.G. Characteristics of the in vitro interaction of a small proteoglycan (PG II) of bovine tendon with type I collagen. Matrix 1989, 9:468-478.
13. Buraschi S., Neill T., Goyal A., Poluzzi C., Smythies J., Owens R.T., Schaefer L., Torres A., Iozzo R.V. Decorin causes autophagy in endothelial cells via Peg3. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E2582-E2591.
14. Calmus M.L., Macksoud E.E., Tucker R., Iozzo R.V., Lechner B.E. A mouse model of spontaneous preterm birth based on the genetic ablation of biglycan and decorin. Reproduction 2011, 142:183-194.
15. Chen S., Sun M., Meng X., Iozzo R.V., Kao W.W., Birk D.E. Pathophysiological mechanisms of autosomal dominant congenital stromal corneal dystrophy: C-terminal-truncated decorin results in abnormal matrix assembly and altered expression of small leucine-rich proteoglycans. Am. J. Pathol. 2011, 179:2409-2419.
16. Corsi A., Xu T., Chen X.D., Boyde A., Liang J., Mankani M., Sommer B., Iozzo R.V., Eichstetter I., Robey P.G., Bianco P., Young M.F. Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J. Bone Miner. Res. 2002, 17:1180-1189.
17. de Vries M.R., Niessen H.W., Lowik C.W., Hamming J.F., Jukema J.W., Quax P.H. Plaque rupture complications in murine atherosclerotic vein grafts can be prevented by TIMP-1 overexpression. PLoS One 2012, 7:e47134.
18. Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003, 425:577-584.
19. El Khwad M., Pandey V., Stetzer B., Mercer B.M., Kumar D., Moore R.M., Fox J., Redline R.W., Mansour J.M., Moore J.J. Fetal membranes from term vaginal deliveries have a zone of weakness exhibiting characteristics of apoptosis and remodeling. J. Soc. Gynecol. Investig. 2006, 13:191-195.
20. Ferrand P.E., Parry S., Sammel M., Macones G.A., Kuivaniemi H., Romero R., Strauss J.F. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol. Hum. Reprod. 2002, 8:494-501.
21. Fortunato S.J., Menon R., Lombardi S.J. MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture. J. Perinat. Med. 1999, 27:362-368.
22. Fortunato S.J., LaFleur B., Menon R. Collagenase-3 (MMP-13) in fetal membranes and amniotic fluid during pregnancy. Am. J. Reprod. Immunol. 2003, 49:120-125.
23. Fujimoto T., Parry S., Urbanek M., Sammel M., Macones G., Kuivaniemi H., Romero R., Strauss J.F. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J. Biol. Chem. 2002, 277:6296-6302.
24. Gogiel T., Bankowski E., Jaworski S. Proteoglycans of Wharton's jelly. Int. J. Biochem. Cell Biol. 2003, 35:1461-1469.
25. Goldoni S., Owens R.T., McQuillan D.J., Shriver Z., Sasisekharan R., Birk D.E., Campbell S., Iozzo R.V. Biologically active decorin is a monomer in solution. J. Biol. Chem. 2004, 279:6606-6612.
26. Goldoni S., Humphries A., Nystrom A., Sattar S., Owens R.T., McQuillan D.J., Ireton K., Iozzo R.V. Decorin is a novel antagonistic ligand of the Met receptor. J. Cell Biol. 2009, 185:743-754.
27. Gomez D., Al Haj Zen A., Borges L.F., Philippe M., Gutierrez P.S., Jondeau G., Michel J.B., Vranckx R. Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway. J. Pathol. 2009, 218:131-142.
28. Guo X., Wang X.F. Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res. 2009, 19:71-88.
29. Heegaard A.M., Corsi A., Danielsen C.C., Nielsen K.L., Jorgensen H.L., Riminucci M., Young M.F., Bianco P. Biglycan deficiency causes spontaneous aortic dissection and rupture in mice. Circulation 2007, 115:2731-2738.
30. Hermanns-Le T., Pierard G., Quatresooz P. Ehlers-Danlos-like dermal abnormalities in women with recurrent preterm premature rupture of fetal membranes. Am. J. Dermatopathol. 2005, 27:407-410.
31. Ichii M., Frank M.B., Iozzo R.V., Kincade P.W. The canonical Wnt pathway shapes niches supportive of hematopoietic stem/progenitor cells. Blood 2012, 119:1683-1692.
32. Iozzo R.V. The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J. Biol. Chem. 1999, 274:18843-18846.
33. Iozzo R.V., Cohen I. Altered proteoglycan gene expression and the tumor stroma. Experientia 1993, 49:447-455.
34. Iozzo R.V., Murdoch A.D. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J. 1996, 10:598-614.
35. Iozzo R.V., Sanderson R.D. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J. Cell. Mol. Med. 2011, 15:1013-1031.
36. Iozzo R.V., Goldoni S., Berendsen A., Young M.F. Small leucine-rich proteoglycans. Extracellular Matrix: An Overview 2011, 197-231. Springer. R.P. Mecham (Ed.).
37. Kim H.S., Luo L., Pflugfelder S.C., Li D.Q. Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 2005, 46:840-848.
38. Kresse H., Rosthoj S., Quentin E., Hollmann J., Glossl J., Okada S., Tonnesen T. Glycosaminoglycan-free small proteoglycan core protein is secreted by fibroblasts from a patient with a syndrome resembling progeroid. Am. J. Hum. Genet. 1987, 41:436-453.
39. Liu F., Hata A., Baker J.C., Doody J., Carcamo J., Harland R.M., Massague J. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 1996, 381:620-623.
40. Malemud C.J. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front. Biosci. 2006, 11:1696-1701.
41. Maymon E., Romero R., Pacora P., Gomez R., Athayde N., Edwin S., Yoon B.H. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection. Am. J. Obstet. Gynecol. 2000, 183:94-99.
42. Meinert M., Eriksen G.V., Petersen A.C., Helmig R.B., Laurent C., Uldbjerg N., Malmstrom A. Proteoglycans and hyaluronan in human fetal membranes. Am. J. Obstet. Gynecol. 2001, 184:679-685.
43. Meinert M., Malmstrom A., Tufvesson E., Westergren-Thorsson G., Petersen A.C., Laurent C., Uldbjerg N., Eriksen G.V. Labour induces increased concentrations of biglycan and hyaluronan in human fetal membranes. Placenta 2007, 28:482-486.
44. Menon R., Fortunato S.J. The role of matrix degrading enzymes and apoptosis in rupture of membranes. J. Soc. Gynecol. Investig. 2004, 11:427-437.
45. Mercado M.L., Amenta A.R., Hagiwara H., Rafii M.S., Lechner B.E., Owens R.T., McQuillan D.J., Froehner S.C., Fallon J.R. Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS. FASEB J. 2006, 20:1724-1726.
46. Merline R., Moreth K., Beckmann J., Nastase M.V., Zeng-Brouwers J., Tralhao J.G., Lemarchand P., Pfeilschifter J., Schaefer R.M., Iozzo R.V., Schaefer L. Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21. Sci. Signal. 2011, 4:ra75.
47. Miyazaki K., Furuhashi M., Yoshida K., Ishikawa K. Aggressive intervention of previable preterm premature rupture of membranes. Acta Obstet. Gynecol. Scand. 2012.
48. Moreth K., Iozzo R.V., Schaefer L. Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation. Cell Cycle 2012, 11:2084-2091.
49. Murphy K.E., Willan A.R., Hannah M.E., Ohlsson A., Kelly E.N., Matthews S.G., Saigal S., Asztalos E., Ross S., Delisle M.F., Amankwah K., Guselle P., Gafni A., Lee S.K. Armson BA; Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study Collaborative Group. Effect of antenatal corticosteroids on fetal growth and gestational age at birth. Obstet Gynecol 2012, 119(5):917-923.
50. Neill T., Painter H., Buraschi S., Owens R.T., Lisanti M.P., Schaefer L., Iozzo R.V. Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1alpha, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. J. Biol. Chem. 2012, 287:5492-5506.
51. Neill T., Schaefer L., Iozzo R.V. Decorin: a guardian from the matrix. Am. J. Pathol. 2012, 181:380-387.
52. Neill T., Jones H.R., Crane-Smith Z., Owens R.T., Schaefer L., Iozzo R.V. Decorin induces rapid secretion of thrombospondin-1 in basal breast carcinoma cells via inhibition of Ras homolog gene family, member A/Rho-associated coiled-coil containing protein kinase 1. FEBS J. 2013, 280:2353-2368.
53. Nikitovic D., Aggelidakis J., Young M.F., Iozzo R.V., Karamanos N.K., Tzanakakis G.N. The biology of small leucine-rich proteoglycans in bone pathophysiology. J. Biol. Chem. 2012, 287:33926-33933.
54. Overall C.M., Wrana J.L., Sodek J. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J. Biol. Chem. 1989, 264:1860-1869.
55. Parry S., Strauss J.F. Premature rupture of the fetal membranes. N. Engl. J. Med. 1998, 338:663-670.
56. Quentin E., Gladen A., Roden L., Kresse H. A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:1342-1346.
57. Reed C.C., Iozzo R.V. The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj. J. 2002, 19:249-255.
58. Reed C.C., Waterhouse A., Kirby S., Kay P., Owens R.T., McQuillan D.J., Iozzo R.V. Decorin prevents metastatic spreading of breast cancer. Oncogene 2005, 24:1104-1110.
59. Riessen R., Isner J.M., Blessing E., Loushin C., Nikol S., Wight T.N. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am. J. Pathol. 1994, 144:962-974.
60. Romero R., Friel L.A., Velez Edwards D.R., Kusanovic J.P., Hassan S.S., Mazaki-Tovi S., Vaisbuch E., Kim C.J., Erez O., Chaiworapongsa T., Pearce B.D., Bartlett J., Salisbury B.A., Anant M.K., Vovis G.F., Lee M.S., Gomez R., Behnke E., Oyarzun E., Tromp G., Williams S.M., Menon R. A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM). Am. J. Obstet. Gynecol. 2010, 203. 361 e361-361 e330.
61. Schaefer L., Iozzo R.V. Small leucine-rich proteoglycans, at the crossroad of cancer growth and inflammation. Curr. Opin. Genet. Dev. 2012, 22:56-57.
62. Schonherr E., Schaefer L., O'Connell B.C., Kresse H. Matrix metalloproteinase expression by endothelial cells in collagen lattices changes during co-culture with fibroblasts and upon induction of decorin expression. J. Cell. Physiol. 2001, 187:37-47.
63. Shah P.K., Falk E., Badimon J.J., Fernandez-Ortiz A., Mailhac A., Villareal-Levy G., Fallon J.T., Regnstrom J., Fuster V. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995, 92:1565-1569.
64. Sofeu Feugaing D.D., Gotte M., Viola M. More than matrix: the multifaceted role of decorin in cancer. Eur. J. Cell Biol. 2013, 92:1-11.
65. Steer P. The epidemiology of preterm labour. BJOG 2005, 112(Suppl. 1):1-3.
66. Sun K., Myatt L. Enhancement of glucocorticoid-induced 11beta-hydroxysteroid dehydrogenase type 1 expression by proinflammatory cytokines in cultured human amnion fibroblasts. Endocrinology 2003, 144:5568-5577.
67. Svensson L., Aszodi A., Reinholt F.P., Fassler R., Heinegard D., Oldberg A. Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J. Biol. Chem. 1999, 274:9636-9647.
68. Tency I., Verstraelen H., Kroes I., Holtappels G., Verhasselt B., Vaneechoutte M., Verhelst R., Temmerman M. Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor. PLoS One 2012, 7:e49042.
69. Vadillo-Ortega F., Estrada-Gutierrez G. Role of matrix metalloproteinases in preterm labour. BJOG 2005, 112(Suppl. 1):19-22.
70. Vadillo-Ortega F., Hernandez A., Gonzalez-Avila G., Bermejo L., Iwata K., Strauss J.F. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am. J. Obstet. Gynecol. 1996, 174:1371-1376.
71. Valiyaveettil M., Achur R.N., Muthusamy A., Gowda D.C. Characterization of chondroitin sulfate and dermatan sulfate proteoglycans of extracellular matrices of human umbilical cord blood vessels and Wharton's jelly. Glycoconj. J. 2004, 21:361-375.
72. Verrecchia F., Chu M.L., Mauviel A. Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J. Biol. Chem. 2001, 276:17058-17062.
73. Wiberg C., Hedbom E., Khairullina A., Lamande S.R., Oldberg A., Timpl R., Morgelin M., Heinegard D. Biglycan and decorin bind close to the n-terminal region of the collagen VI triple helix. J. Biol. Chem. 2001, 276:18947-18952.
74. Xu T., Bianco P., Fisher L.W., Longenecker G., Smith E., Goldstein S., Bonadio J., Boskey A., Heegaard A.M., Sommer B., Satomura K., Dominguez P., Zhao C., Kulkarni A.B., Robey P.G., Young M.F. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat. Genet. 1998, 20:78-82.
75. Yamaguchi Y., Mann D.M., Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990, 346:281-284.
76. Yen J.L., Lin S.P., Chen M.R., Niu D.M. Clinical features of Ehlers-Danlos syndrome. J. Formos. Med. Assoc. 2006, 105:475-480.
77. Zhang G., Chen S., Goldoni S., Calder B.W., Simpson H.C., Owens R.T., McQuillan D.J., Young M.F., Iozzo R.V., Birk D.E. Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan. J. Biol. Chem. 2009, 284:8888-8897.